Abstract

Many microorganisms, including bacteria of the class Streptomycetes, produce various secondary metabolites including antibiotics to gain a competitive advantage in their natural habitat. The production of these compounds is highly coordinated in a population to expedite accumulation to an effective concentration. Furthermore, as antibiotics are often toxic even to their producers, a coordinated production allows microbes to first arm themselves with a defense mechanism to resist their own antibiotics before production commences. One possible mechanism of coordination among individuals is through the production of signaling molecules. The γ-butyrolactone system in Streptomyces coelicolor is a model of such a signaling system for secondary metabolite production. The accumulation of these signaling molecules triggers antibiotic production in the population. A pair of repressor-amplifier proteins encoded by scbA and scbR mediates the production and action of one particular γ-butyrolactone, SCB1. Based on the proposed interactions of scbA and scbR, a mathematical model was constructed and used to explore the ability of this system to act as a robust genetic switch. Stability analysis shows that the butyrolactone system exhibits bistability and, in response to a threshold SCB1 concentration, can switch from an OFF state to an ON state corresponding to the activation of genes in the cryptic type I polyketide synthase gene cluster, which are responsible for production of the hypothetical polyketide. The switching time is inversely related to the inducer concentration above the threshold, such that short pulses of low inducer concentration cannot switch on the system, suggesting its possible role in noise filtering. In contrast, secondary metabolite production can be triggered rapidly in a population of cells producing the butyrolactone signal due to the presence of an amplification loop in the system. S. coelicolor was perturbed experimentally by varying concentrations of SCB1, and the model simulations match the experimental data well. Deciphering the complexity of this butyrolactone switch will provide valuable insights into how robust and efficient systems can be designed using “simple” two-protein networks.

Highlights

  • Many microorganisms make antibiotics that confer a competitive advantage for their survival

  • As antibiotics are often toxic even to their producers, microbes first express a defense mechanism to resist their own antibiotics before turning these weapons against others

  • Coordination within members of a population is critical because uncoordinated antibiotic production by some members could be fatal for others of the same species in the population which fail to equip themselves with a defense mechanism

Read more

Summary

Introduction

Many microorganisms make antibiotics that confer a competitive advantage for their survival. Streptomycetes (genus Streptomyces) in particular produce nearly 70% of antibiotics in clinical use [1]. These are soil microorganisms, which in their natural habitat grow in small colonies in an environment where the physical and chemical conditions fluctuate constantly. The arsenal of antibiotics helps them compete with other organisms in the soil environment under stresses due to various adverse conditions. Coordination within members of a population is critical because uncoordinated antibiotic production by some members could be fatal for others of the same species in the population which fail to equip themselves with a defense mechanism

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call